Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
ALLO
Shares outstanding
218,789,361 shares
Disclosed Ownership
13,346,151 shares
Ownership
6.1%
Form type
SCHEDULE 13G
Filing time
16 Jul 2025, 18:02:33 UTC
Date of event
09 Jul 2025

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 6.1% ownership in Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ALLO) on 09 Jul 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G for Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ALLO).
  • Disclosed ownership: 6.1%.
  • Date of event: 09 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Jul 2025, 18:02.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.7% 10,203,329 0 10,203,329 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.7% 10,203,329 0 10,203,329 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.7% 10,203,329 0 10,203,329 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 1.4% 3,142,822 0 3,142,822 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 1.4% 3,142,822 0 3,142,822 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 1.4% 3,142,822 0 3,142,822 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 6.1% 13,346,151 0 13,346,151 /s/ Seth Levy Seth Levy, attorney-in-fact*